Sanofi: Atrial Fibrillation trials
The registry lists 23 Atrial Fibrillation studies with Sanofi as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 2 3Phase 3 12Phase 4 6No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial EnlargementTerminatedNCT01198873Phase 4Results posted
- Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard TherapyTerminatedNCT01151137Phase 3Results posted
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent PacemakersTerminatedNCT01135017Phase 4Results posted
- Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCompletedNCT00489736Phase 3Results posted
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)CompletedNCT00249873Phase 3Results posted
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)CompletedNCT00249795Phase 3Results posted
- A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial FibrillationCompletedNCT00174785Phase 3Results posted
- Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial FibrillationCompletedNCT05279833
- Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial FibrillationCompletedNCT01213368Phase 2
- Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial FibrillationCompletedNCT01199081Phase 4
- Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial FibrillationCompletedNCT01140581Phase 4
- Observatory on Elderly Patients "Les S.AGES"CompletedNCT01065909
- Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)CompletedNCT01047566Phase 4
- Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)TerminatedNCT01026090Phase 4
- The RECORD Asia-Pacific Atrial Fibrillation RegistryCompletedNCT00995748
- European Study of Dronedarone in Atrial FibrillationCompletedNCT00697086Phase 3
- Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial FibrillationTerminatedNCT00580216Phase 3
- EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)CompletedNCT00259428Phase 3
- American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus RhythmCompletedNCT00259376Phase 3
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TerminatedNCT00243178Phase 3
- Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/FlutterCompletedNCT00233441Phase 2/3
- Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttErCompletedNCT00232310Phase 2
- Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)CompletedNCT00070655Phase 3